Literature DB >> 31760922

Neutral Endopeptidase (Neprilysin) in Therapy and Diagnostics: Yin and Yang.

E E Feygina1,2, A G Katrukha3,4, A G Semenov3,2.   

Abstract

Neprilysin (NEP) is a zinc-dependent metalloproteinase that exists in organisms in both transmembrane and soluble forms. NEP substrates are involved in regulating the cardiovascular and nervous systems. In this review, we discuss some of the biochemical characteristics and physiological functions of this enzyme with special emphasis on the use of NEP as a therapeutic target. The history and various physiological aspects of applying NEP inhibitors for treating heart failure and attempts to increase NEP activity when treating Alzheimer's disease using gene and cell therapies are described. Another important issue discussed is the role of NEP as a potential marker for predicting the risk of cardiovascular disease complications. The diagnostic and prognostic performance of soluble NEP in various types of heart failure is analyzed and presented. We also discuss the methods and approaches for measuring NEP activity for prognosis and diagnosis, as well as a possible new role of natriuretic peptides (NEP substrates) in cardiovascular diagnostics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31760922     DOI: 10.1134/S0006297919110105

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  7 in total

Review 1.  European Medicinal Leeches-New Roles in Modern Medicine.

Authors:  Sarah Lemke; Andreas Vilcinskas
Journal:  Biomedicines       Date:  2020-04-27

Review 2.  Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease.

Authors:  Namdoo Kim; Hyuck Jin Lee
Journal:  Biomed Res Int       Date:  2020-11-09       Impact factor: 3.411

Review 3.  The "Elastic Perspective" of SARS-CoV-2 Infection and the Role of Intrinsic and Extrinsic Factors.

Authors:  Federica Boraldi; Francesco Demetrio Lofaro; Andrea Cossarizza; Daniela Quaglino
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

4.  Extracellular Vesicles Released from Neprilysin Gene-Modified Human Umbilical Cord-Derived Mesenchymal Stem Cell Enhance Therapeutic Effects in an Alzheimer's Disease Animal Model.

Authors:  HyeJu Jeong; Ok Joon Kim; Seung-Hun Oh; Sanghoon Lee; Han A Reum Lee; Kee Ook Lee; Boo-Yong Lee; Nam Keun Kim
Journal:  Stem Cells Int       Date:  2021-12-03       Impact factor: 5.443

5.  The Potential Role of Serum Tau Protein (MAPT), Neuronal Cell Adhesion Molecule (NrCAM) and Neprilysin (NEP) in Neurodegenerative Disorders Development in Psoriasis-Preliminary Results.

Authors:  Anna Baran; Julia Nowowiejska; Justyna Magdalena Hermanowicz; Beata Sieklucka; Julita Anna Krahel; Paulina Kiluk; Dariusz Pawlak; Iwona Flisiak
Journal:  J Clin Med       Date:  2022-08-27       Impact factor: 4.964

6.  Multiplex enzyme activity imaging by MALDI-IMS of substrate library conversions.

Authors:  Oliver Klein; Akvile Haeckel; Ulf Reimer; Grit Nebrich; Eyk Schellenberger
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

7.  Tripchlorolide attenuates β-amyloid generation by inducing NEP activity in N2a/APP695 cells.

Authors:  Yuqi Zeng; Yongkun Li; Hui Shen; Nan Lin; Jian Zhang
Journal:  Transl Neurosci       Date:  2021-07-20       Impact factor: 1.757

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.